CAT No: CP01433
CAS No:156648-40-7
Synonyms/Alias:Dde-Lys(Fmoc)-OH;156648-40-7;L-Lysine, N2-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]-N6-[(9H-fluoren-9-ylmethoxy)carbonyl]-;(2S)-6-(9H-fluoren-9-ylmethoxycarbonylamino)-2-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]hexanoic acid;dde-l-lys(fmoc)-oh;MFCD00467662;N6-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)-L-lysine;(2S)-2-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethylamino]-6-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid;(2S)-2-{[1-(4,4-DIMETHYL-2,6-DIOXOCYCLOHEXYLIDENE)ETHYL]AMINO}-6-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}HEXANOIC ACID;L-Lysine, N2-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)-N6-((9H-fluoren-9-ylmethoxy)carbonyl)-;n-alpha-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-n-epsilon-fmoc-l-lysine;SCHEMBL3502087;DTXSID80679793;HJGADLBSAXYSSH-VWLOTQADSA-N;XH1414;AKOS015911819;DS-15038;CS-0137316;F10658;N^a-1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-N^e-Fmoc-L-lysine;N-alpha-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-N-epsilon-(9-Fmoc)-L-lysine;(S)-6-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethylamino)hexanoic acid;812-215-4;N~2~-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-N~6~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-lysine;
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.